A Rare Opportunity? NIH Program For Rare Diseases May Have Big Payoff For Drug Development
NIH Director Francis Collins is very excited about a $24 million program to de-risk small molecule treatments for rare disorders. You should be too.
NIH Director Francis Collins is very excited about a $24 million program to de-risk small molecule treatments for rare disorders. You should be too.